Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company (“PHAXIAM” or “the Company”) developing innovative ...

Hyderabad: Granules India Limited has announced that the Company's Unit V facility located at Anakapally, Visakhapatnam, ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...

The medical cannabis product is launched under the brand IndiMed and manufactured at Aurora's EU-GMP facility in Leuna, Germany.

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

Aurora Cannabis (TSX:ACB), a global cannabis stock, is releasing its first German-cultivated dried flower product under the IndiMed brand on January 27 ・The strain, Island Sweet Skunk, is a ...

Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.

“HYTN holds both a Drug Establishment License and EU GMP equivalent certification under the International Pharmaceutical Cooperation Scheme (PIC/S), making it one of the few facilities in Canada ...

Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...

Curaleaf Holdings down 68% in a year, with 66 dispensaries in Florida. Q324 showed in-line results and international growth.